US3119739A - Acetylmethyl-salicylate for pain relief - Google Patents

Acetylmethyl-salicylate for pain relief Download PDF

Info

Publication number
US3119739A
US3119739A US107318A US10731861A US3119739A US 3119739 A US3119739 A US 3119739A US 107318 A US107318 A US 107318A US 10731861 A US10731861 A US 10731861A US 3119739 A US3119739 A US 3119739A
Authority
US
United States
Prior art keywords
methyl salicylate
salicylate
pain
prepared
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US107318A
Inventor
Wanda L Campbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US107318A priority Critical patent/US3119739A/en
Application granted granted Critical
Publication of US3119739A publication Critical patent/US3119739A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Definitions

  • My invention relates to a new method for the alleviation of surface pain in the form of itching, hives, rashes and bites and stings of insects, and more particularly, it relates to the alleviation of such forms of pain by the application to the affected areas of the body compositions comprising as an essential active ingredient acetyl methyl salicylate.
  • My invention is concerned with the alleviation of different forms of pain which normally occur on the surface of the human body in the form of hives, rashes and the like, or by the bites or stings of insects such as bees, ants, wasps, chiggers and the like, which are usually followed by pain in the form of intense itching and the formation of welts.
  • the application of my new anodyne agent to surfaces so aifected rapidly and usually completely eliminates such forms of pain. It should however, in no sense be regarded as a curative agent for the basic cause of the pain.
  • the essential active ingredient of my new anodyne agent is acetyl methyl salicylate used preferably in the form of a l-20% by weight solution or suspension thereof in a suitable inert pharmaceutical carrier.
  • the inert carrier for the acetyl methyl salicylate can be varied somewhat depending upon the preferred method and form of application, as well as the concentration of the active ingredient and can be employed satisfactorily in either lotion or ointment form.
  • acetyl methyl salicylate I can also use other ingredients to aid and supplement the effect of the acetyl methyl salicylate, so long as such added ingredients meet the same definition for inertness set forth above.
  • ingredients include perfumes to improve the odor of the composition, lanolin to prevent the drying of the skin on which the composition is used, emulsifying and suspending agents if a non-solvent for the acetyl methyl salicylate is employed, agents such as oils and waxes to give body to the composition when used in ointment form, as well as other ingredients well-known to those skilled in the art.
  • Example I An ointment was prepared by thoroughly mixing 20 g. of acetyl methyl salicylate with g. of either Carbowax 1500 or Carbowax 1540 (polyethylene glycols made by Carbide & Carbon Chemicals Corporation).
  • the resulting composition was in the form of a semihard ointment which could be easily spread upon the affected surfaces of the skin.
  • Example II A lotion containing acetyl methyl salicylate was prepared in suitable form for application to the skin as follows:
  • a mixture of 9 g. lanolin, 50 g. stearic acid and 10 g. acetyl methyl salicylate was prepared and heated to 70 C.
  • a second mixture consisting of l g. 2-amino-2-methyl-1,3-propanediol, 18 g. propylene glycol and 120 g. of water was prepared, heated to 70 C. and then thoroughly mixed with the previously prepared and heated mixture of lanolin, stearic acid and acetyl methyl salicylate.
  • Example III Another suitable form of lotion was prepared as follows:
  • a mixture of 45 g. stearic acid, 12 g. white oil, 20 g. lanolin and g. amino methyl salicylate was prepared and heated to 70 C. To this was then added a similarly prepared mixture of 15 g. 2-arnino-2-methyl-l,3- propanediol, 100 g. glycerine, 150 g. specially denatured B.A. alcohol, and 1,150 g. of water, this mixture being similarly heated to 70 C. before the mixing. To the resulting mixture was then added a mixture of 5 g. Kraystay (a specially purified extract of carrageen or Irish moss) and 500 g. water. This mixture was then added to the mixture of ingredients prepared as above described and gave a highly satisfactory form of lotion.
  • Kraystay a specially purified extract of carrageen or Irish moss
  • Example IV My new anodyne composition in a vanishing cream ointment base was prepared as follows:
  • a mixture of 9 g. of lanolin, 50 g. stearic acid and 10 g. acetyl methyl salicylate was first prepared and heated to 70 C.
  • a second mixture consisting of 1 g. :amino methyl propanediol, 18 g. propylene glycol, g. water and perfume as desired was prepared and similarly heated to 70 C. The two mixtures were then thoroughly mixed with agitation and stirred until cold.
  • My new anodyne composition in each of the forms illustrated above has been found to be effective in giving immediate relief of the irritation caused by chigger biting and in most cases, no severe hemorrhagic development from the bites. It has likewise been effective in stopping the swelling and pain of wasp stings and mosquito bites.
  • the application of the anodyne agent in ointment form has been found to be particularly effective in stopping the 3 itching and blistering of the arms and face caused by allergies resulting from wheat, grasses, etc.
  • a method for the alleviation of pain occuring on the surface of the human body and resulting from the bites and stings of insects and from hives and rashes which comprises applying to the affected areas compositions containing as the essential active ingredient from 1 to 20% by weight of acetyl methyl salicylate.

Description

United States Patent 3,119,739 ACETYLMETHYL-SALICYLAIE FOR PAIN RELIEF Wanda L. Campbell, 123 Jackson Blvd, Terre Haute, Ind.
No Drawing. Filed May 3, 1961, Ser. No. 107,318 1 Claim. (Cl. 167-58) My invention relates to a new method for the alleviation of surface pain in the form of itching, hives, rashes and bites and stings of insects, and more particularly, it relates to the alleviation of such forms of pain by the application to the affected areas of the body compositions comprising as an essential active ingredient acetyl methyl salicylate.
Pain occurs in many different forms and degrees as well as in different parts of the body and accordingly many dilferent types of agents are required for the alleviation of these different kinds and forms of pain. My invention is concerned with the alleviation of different forms of pain which normally occur on the surface of the human body in the form of hives, rashes and the like, or by the bites or stings of insects such as bees, ants, wasps, chiggers and the like, which are usually followed by pain in the form of intense itching and the formation of welts. The application of my new anodyne agent to surfaces so aifected rapidly and usually completely eliminates such forms of pain. It should however, in no sense be regarded as a curative agent for the basic cause of the pain.
The essential active ingredient of my new anodyne agent is acetyl methyl salicylate used preferably in the form of a l-20% by weight solution or suspension thereof in a suitable inert pharmaceutical carrier. The inert carrier for the acetyl methyl salicylate can be varied somewhat depending upon the preferred method and form of application, as well as the concentration of the active ingredient and can be employed satisfactorily in either lotion or ointment form. In general, I can use as the inert carrier any agents customarily used in making lotions or ointments suitable for application to the human skin and which are at the same time inert to the actyl methyl salicylate, that is, which do not react with or decompose the :actyl methyl salicylate under the conditions of manufacture, storage and use of the anodyne composition. Agents which are also solvents for the acetyl methyl salicylate to the degree required are preferred but suspensions or emulsions of the actyl methyl salicylate can be satisfactorily used. When used in such forms, however, the acetyl methyl salicylate is preferably employed in finely divided form. Suitable inert solvent carriers for the actyl methyl salicylate include ethanol, isopropanol, and polyethylene glycols.
With the active agent of my new anodyne composition, acetyl methyl salicylate, I can also use other ingredients to aid and supplement the effect of the acetyl methyl salicylate, so long as such added ingredients meet the same definition for inertness set forth above. Such ingredients include perfumes to improve the odor of the composition, lanolin to prevent the drying of the skin on which the composition is used, emulsifying and suspending agents if a non-solvent for the acetyl methyl salicylate is employed, agents such as oils and waxes to give body to the composition when used in ointment form, as well as other ingredients well-known to those skilled in the art.
The following specific examples will illustrate the com position and method of producing my new anodyne composition but it is distinctly understood that I am not limited either to the specific methods of manufacture set forth therein or to the specific ingredients used in these specific examples which are given merely to illustrate the production of my new anodyne compositions containing acetyl methyl salicylate using any of the customary methods of making either lotions or ointments.
Example I An ointment was prepared by thoroughly mixing 20 g. of acetyl methyl salicylate with g. of either Carbowax 1500 or Carbowax 1540 (polyethylene glycols made by Carbide & Carbon Chemicals Corporation).
The resulting composition was in the form of a semihard ointment which could be easily spread upon the affected surfaces of the skin.
Example II A lotion containing acetyl methyl salicylate was prepared in suitable form for application to the skin as follows:
A mixture of 9 g. lanolin, 50 g. stearic acid and 10 g. acetyl methyl salicylate was prepared and heated to 70 C. A second mixture consisting of l g. 2-amino-2-methyl-1,3-propanediol, 18 g. propylene glycol and 120 g. of water was prepared, heated to 70 C. and then thoroughly mixed with the previously prepared and heated mixture of lanolin, stearic acid and acetyl methyl salicylate.
Example III Another suitable form of lotion was prepared as follows:
A mixture of 45 g. stearic acid, 12 g. white oil, 20 g. lanolin and g. amino methyl salicylate was prepared and heated to 70 C. To this was then added a similarly prepared mixture of 15 g. 2-arnino-2-methyl-l,3- propanediol, 100 g. glycerine, 150 g. specially denatured B.A. alcohol, and 1,150 g. of water, this mixture being similarly heated to 70 C. before the mixing. To the resulting mixture was then added a mixture of 5 g. Kraystay (a specially purified extract of carrageen or Irish moss) and 500 g. water. This mixture was then added to the mixture of ingredients prepared as above described and gave a highly satisfactory form of lotion.
Example IV My new anodyne composition in a vanishing cream ointment base was prepared as follows:
A mixture of 9 g. of lanolin, 50 g. stearic acid and 10 g. acetyl methyl salicylate was first prepared and heated to 70 C. A second mixture consisting of 1 g. :amino methyl propanediol, 18 g. propylene glycol, g. water and perfume as desired was prepared and similarly heated to 70 C. The two mixtures were then thoroughly mixed with agitation and stirred until cold.
My new anodyne composition in each of the forms illustrated above has been found to be effective in giving immediate relief of the irritation caused by chigger biting and in most cases, no severe hemorrhagic development from the bites. It has likewise been effective in stopping the swelling and pain of wasp stings and mosquito bites. The application of the anodyne agent in ointment form has been found to be particularly effective in stopping the 3 itching and blistering of the arms and face caused by allergies resulting from wheat, grasses, etc.
Now having described my invention, what I claim as new and novel is:
A method for the alleviation of pain occuring on the surface of the human body and resulting from the bites and stings of insects and from hives and rashes, which comprises applying to the affected areas compositions containing as the essential active ingredient from 1 to 20% by weight of acetyl methyl salicylate.
References Cited in the file of this patent UNITED STATES PATENTS 1,951,737 Nitardy Mar. 20, 1934 4 OTHER REFERENCES
US107318A 1961-05-03 1961-05-03 Acetylmethyl-salicylate for pain relief Expired - Lifetime US3119739A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US107318A US3119739A (en) 1961-05-03 1961-05-03 Acetylmethyl-salicylate for pain relief

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US107318A US3119739A (en) 1961-05-03 1961-05-03 Acetylmethyl-salicylate for pain relief

Publications (1)

Publication Number Publication Date
US3119739A true US3119739A (en) 1964-01-28

Family

ID=22316019

Family Applications (1)

Application Number Title Priority Date Filing Date
US107318A Expired - Lifetime US3119739A (en) 1961-05-03 1961-05-03 Acetylmethyl-salicylate for pain relief

Country Status (1)

Country Link
US (1) US3119739A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988446A (en) * 1974-11-07 1976-10-26 Abbott Laboratories Glycerides with anti-inflammatory properties
US4199576A (en) * 1976-12-15 1980-04-22 The Procter & Gamble Company Analgesic and anti-inflammatory compositions for topical application
WO1983003424A1 (en) * 1982-03-24 1983-10-13 Bateman, Neil, E. Acetylsalicylic acid derivatives and process for the preparation thereof
US4546197A (en) * 1982-03-24 1985-10-08 R. P. Scherer Corporation Pharmaceutical composition and process for the manufacture thereof
US4987127A (en) * 1989-01-31 1991-01-22 Dal Sirany Method of treating a virus outbreak
US5736126A (en) * 1996-03-15 1998-04-07 Van Engelen; H. Wayne Liquid transdermal analgesic
US20020013300A1 (en) * 2000-03-17 2002-01-31 Avocet Polymer Technologies, Inc. Methods for improving size and appearance of a wound
US7985743B1 (en) 2005-07-22 2011-07-26 Gene A. Tabish Topical pain reliever and method of making the same
EP2452670A1 (en) 2004-10-01 2012-05-16 Ramscor, Inc. Conveniently implantable sustained release drug compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1951737A (en) * 1933-03-31 1934-03-20 Squibb & Sons Inc Compositions, containing an alkyl salicylate and an alkali-metal stearate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1951737A (en) * 1933-03-31 1934-03-20 Squibb & Sons Inc Compositions, containing an alkyl salicylate and an alkali-metal stearate

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988446A (en) * 1974-11-07 1976-10-26 Abbott Laboratories Glycerides with anti-inflammatory properties
US4199576A (en) * 1976-12-15 1980-04-22 The Procter & Gamble Company Analgesic and anti-inflammatory compositions for topical application
WO1983003424A1 (en) * 1982-03-24 1983-10-13 Bateman, Neil, E. Acetylsalicylic acid derivatives and process for the preparation thereof
US4546197A (en) * 1982-03-24 1985-10-08 R. P. Scherer Corporation Pharmaceutical composition and process for the manufacture thereof
US4987127A (en) * 1989-01-31 1991-01-22 Dal Sirany Method of treating a virus outbreak
US5736126A (en) * 1996-03-15 1998-04-07 Van Engelen; H. Wayne Liquid transdermal analgesic
US20020013300A1 (en) * 2000-03-17 2002-01-31 Avocet Polymer Technologies, Inc. Methods for improving size and appearance of a wound
EP2452670A1 (en) 2004-10-01 2012-05-16 Ramscor, Inc. Conveniently implantable sustained release drug compositions
EP3173072A1 (en) 2004-10-01 2017-05-31 Ramscor, Inc. Conveniently implantable sustained release drug compositions
US7985743B1 (en) 2005-07-22 2011-07-26 Gene A. Tabish Topical pain reliever and method of making the same

Similar Documents

Publication Publication Date Title
US5670547A (en) Moisturizing vehicle for topical application of vitamin A acid
US5990100A (en) Composition and method for treatment of psoriasis
US4545990A (en) Anti-acne composition
US4247547A (en) Tretinoin in a gel vehicle for acne treatment
US4542129A (en) DHEA Formulations and methods for treating dry skin
US3749773A (en) Gelled steroid ointment
AU570639B2 (en) Corticoid topical formulation
JPS60104005A (en) Skin beutifying cosmetic
DE1667237A1 (en) Pressurized preparation and its manufacture
US3119739A (en) Acetylmethyl-salicylate for pain relief
US4310525A (en) Method of treatment of inflammation
US4062937A (en) Insect bite relief preparation
US4239781A (en) Method for treating skin ailments
JPH02152928A (en) Antistimulant and desensitizing composition and its usage
US4797402A (en) Cooling anti-itch skin preparations
US3663716A (en) Method of treating acne with benzyl alcohol
US5886038A (en) Composition and method for treatment of psoriasis
US2460776A (en) Bacteriostatic base for medicinal, cosmetic, and toilet preparations
EP0175701A1 (en) Skin treatment compositions
US3193451A (en) Fungicidal composition of undecylenic acid derivatives
JPH0532556A (en) Skin agent for external use
EP0129014A1 (en) Deodorizing cosmetic composition
US4752620A (en) Method of treating pain with urea and glyoxal compositions
US5716606A (en) Lotion-based sulfur preparation for skin treatment
DE2725765C2 (en)